PMV Pharmaceuticals GAAP EPS of -$1.28 misses by $0.05
- PMV Pharmaceuticals press release (NASDAQ:PMVP): FY GAAP EPS of -$1.28 misses by $0.05.
- Cash, cash equivalents, and marketable securities as of December 31, 2021 of $314.4M compared to $361.4 million as of December 31, 2020.
Recommended For You
Comments
Have a tip? Submit confidentially to our News team. Found a factual error? Report here.